Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictor

Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictor

Abstract Background Our previous studies showed that vasoconstrictor applied topically to rat skin minutes before irradiation completely prevented radiodermatitis. Here we report on a Phase IIa study of topically applied NG12-1 vasoconstrictor to prevent radiodermatitis in post-lumpectomy breast can...

Full description

Bibliographic Details
Main Authors: James F. Cleary, Bethany M. Anderson, Jens C. Eickhoff, Deepak Khuntia, William E. Fahl
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Radiation Oncology
Subjects:
ROS
Phase IIa clinical trial
Online Access:http://link.springer.com/article/10.1186/s13014-017-0940-7

Internet

http://link.springer.com/article/10.1186/s13014-017-0940-7

Similar Items